PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Pentoxifylline - Pre-operative / bridging therapy
PAD Profile : Pentoxifylline - Pre-operative / bridging therapy
Keywords :
osteonecrosis of the jaw, ORN, ONJ
Traffic Light Status
Status 1 of 1.
Status :
Red
Important
Formulations :
- Modified release tablets
Important Information :
Restricted to Oral Surgeons only - with Vitamin E to start 1 week before extraction and for 3 months after (until good healing is observed)
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Comments :
No comments returned.
Documents :
Guidelines
No guidelines returned.
Other Drugs
Other Indications
Additional Documents
No additional documents returned.
Committee Recommendations
Date
Committee Name
Narrative
05 February 2025
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)
This drug has been included on the joint formulary having been agreed by the DTC of at least one Surrey Heartlands Acute Trust.
See “Formulary Status” to identify where this drug has been agreed for use.
Associated BNF Codes
No BNF codes returned.